HIFs, angiogenesis, and cancer
Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multi...
Gespeichert in:
Veröffentlicht in: | Journal of cellular biochemistry 2013-05, Vol.114 (5), p.967-974 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 974 |
---|---|
container_issue | 5 |
container_start_page | 967 |
container_title | Journal of cellular biochemistry |
container_volume | 114 |
creator | Yang, Yongzhi Sun, Mingjuan Wang, Lianghua Jiao, Binghua |
description | Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/jcb.24438 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1317858275</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2917708271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</originalsourceid><addsrcrecordid>eNp10MtKw0AUBuBBFFurC1-gFNwoGDvXzGSpwV6k6KZYcDNMJiclNU1qpkH79qZN24UgDBwGvvNz-BG6JviBYEz7Cxs9UM6ZOkFtggPpcZ_zU9TGkmGPMkJb6MK5BcY4CBg9Ry3KKBX1a6PuaDxw9z2Tz9NiDjm4dPeLe9bkFspLdJaYzMHVfnbQdPA8DUfe5G04Dh8nnuVCKo8aAhgTAzSKrRCJAoqJr0wMsYiUtJZDrAKaMGMhCSKQSYRJwgSVQcATwjrotoldlcVXBW6tl6mzkGUmh6JymjAilVBUipre_KGLoirz-rit8gPqC8FqddcoWxbOlZDoVZkuTbnRBOttZ7ruTO86q213n1hFS4iP8lBSDfoN-E4z2PyfpF_Cp0Ok12ykbg0_xw1TfmpfMin07HWoxTvjsxBL_cF-AVHKgV4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1316926553</pqid></control><display><type>article</type><title>HIFs, angiogenesis, and cancer</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Yang, Yongzhi ; Sun, Mingjuan ; Wang, Lianghua ; Jiao, Binghua</creator><creatorcontrib>Yang, Yongzhi ; Sun, Mingjuan ; Wang, Lianghua ; Jiao, Binghua</creatorcontrib><description>Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.24438</identifier><identifier>PMID: 23225225</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>ANGIOGENESIS ; Animals ; CANCER ; Humans ; Hypoxia-Inducible Factor 1 - chemistry ; Hypoxia-Inducible Factor 1 - genetics ; Hypoxia-Inducible Factor 1 - metabolism ; HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) ; Models, Biological ; Neoplasms - blood supply ; Neoplasms - metabolism ; Neoplasms - pathology ; Neovascularization, Pathologic - metabolism ; Signal Transduction</subject><ispartof>Journal of cellular biochemistry, 2013-05, Vol.114 (5), p.967-974</ispartof><rights>Copyright © 2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</citedby><cites>FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.24438$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.24438$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23225225$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Yongzhi</creatorcontrib><creatorcontrib>Sun, Mingjuan</creatorcontrib><creatorcontrib>Wang, Lianghua</creatorcontrib><creatorcontrib>Jiao, Binghua</creatorcontrib><title>HIFs, angiogenesis, and cancer</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.</description><subject>ANGIOGENESIS</subject><subject>Animals</subject><subject>CANCER</subject><subject>Humans</subject><subject>Hypoxia-Inducible Factor 1 - chemistry</subject><subject>Hypoxia-Inducible Factor 1 - genetics</subject><subject>Hypoxia-Inducible Factor 1 - metabolism</subject><subject>HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1)</subject><subject>Models, Biological</subject><subject>Neoplasms - blood supply</subject><subject>Neoplasms - metabolism</subject><subject>Neoplasms - pathology</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Signal Transduction</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10MtKw0AUBuBBFFurC1-gFNwoGDvXzGSpwV6k6KZYcDNMJiclNU1qpkH79qZN24UgDBwGvvNz-BG6JviBYEz7Cxs9UM6ZOkFtggPpcZ_zU9TGkmGPMkJb6MK5BcY4CBg9Ry3KKBX1a6PuaDxw9z2Tz9NiDjm4dPeLe9bkFspLdJaYzMHVfnbQdPA8DUfe5G04Dh8nnuVCKo8aAhgTAzSKrRCJAoqJr0wMsYiUtJZDrAKaMGMhCSKQSYRJwgSVQcATwjrotoldlcVXBW6tl6mzkGUmh6JymjAilVBUipre_KGLoirz-rit8gPqC8FqddcoWxbOlZDoVZkuTbnRBOttZ7ruTO86q213n1hFS4iP8lBSDfoN-E4z2PyfpF_Cp0Ok12ykbg0_xw1TfmpfMin07HWoxTvjsxBL_cF-AVHKgV4</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Yang, Yongzhi</creator><creator>Sun, Mingjuan</creator><creator>Wang, Lianghua</creator><creator>Jiao, Binghua</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>HIFs, angiogenesis, and cancer</title><author>Yang, Yongzhi ; Sun, Mingjuan ; Wang, Lianghua ; Jiao, Binghua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4578-2a1e001ae2bdc55f8e20168aded5b87cc4ed892f3acef9be7fb01f3527994f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>ANGIOGENESIS</topic><topic>Animals</topic><topic>CANCER</topic><topic>Humans</topic><topic>Hypoxia-Inducible Factor 1 - chemistry</topic><topic>Hypoxia-Inducible Factor 1 - genetics</topic><topic>Hypoxia-Inducible Factor 1 - metabolism</topic><topic>HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1)</topic><topic>Models, Biological</topic><topic>Neoplasms - blood supply</topic><topic>Neoplasms - metabolism</topic><topic>Neoplasms - pathology</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Yongzhi</creatorcontrib><creatorcontrib>Sun, Mingjuan</creatorcontrib><creatorcontrib>Wang, Lianghua</creatorcontrib><creatorcontrib>Jiao, Binghua</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Yongzhi</au><au>Sun, Mingjuan</au><au>Wang, Lianghua</au><au>Jiao, Binghua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIFs, angiogenesis, and cancer</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2013-05</date><risdate>2013</risdate><volume>114</volume><issue>5</issue><spage>967</spage><epage>974</epage><pages>967-974</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Tumor hypoxia was first described in the 1950s by radiation oncologists as a frequent cause of failure to radiotherapy in solid tumors. Today, it is evident that tumor hypoxia is a common feature of many cancers and the master regulator of hypoxia, hypoxia‐inducible factor‐1 (HIF‐1), regulates multiple aspects of tumorigenesis, including angiogenesis, proliferation, metabolism, metastasis, differentiation, and response to radiation therapy. Although the tumor hypoxia response mechanism leads to a multitude of downstream effects, it is angiogenesis that is most crucial and also most susceptible to molecular manipulation. The delineation of molecular mechanisms of angiogenesis has revealed a critical role for HIF‐1 in the regulation of angiogenic growth factors. In this article, we review what has been described about HIF‐1: its structure, its regulation, and its implication for cancer therapy and we focus on its role in angiogenesis and cancer. J. Cell. Biochem. 114: 967–974, 2013. © 2012 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>23225225</pmid><doi>10.1002/jcb.24438</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0730-2312 |
ispartof | Journal of cellular biochemistry, 2013-05, Vol.114 (5), p.967-974 |
issn | 0730-2312 1097-4644 |
language | eng |
recordid | cdi_proquest_miscellaneous_1317858275 |
source | MEDLINE; Access via Wiley Online Library |
subjects | ANGIOGENESIS Animals CANCER Humans Hypoxia-Inducible Factor 1 - chemistry Hypoxia-Inducible Factor 1 - genetics Hypoxia-Inducible Factor 1 - metabolism HYPOXIA-INDUCIBLE FACTOR-1 (HIF-1) Models, Biological Neoplasms - blood supply Neoplasms - metabolism Neoplasms - pathology Neovascularization, Pathologic - metabolism Signal Transduction |
title | HIFs, angiogenesis, and cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A17%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIFs,%20angiogenesis,%20and%20cancer&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Yang,%20Yongzhi&rft.date=2013-05&rft.volume=114&rft.issue=5&rft.spage=967&rft.epage=974&rft.pages=967-974&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.24438&rft_dat=%3Cproquest_cross%3E2917708271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1316926553&rft_id=info:pmid/23225225&rfr_iscdi=true |